Literature DB >> 15919849

Weight change and risk of developing type 2 diabetes.

Yuko Oguma1, Howard D Sesso, Ralph S Paffenbarger, I-Min Lee.   

Abstract

OBJECTIVE: To examine the association between weight change and risk of type 2 diabetes and whether initial weight modifies the association. RESEARCH METHODS AND PROCEDURES: This is a prospective cohort study of 20,187 alumni from Harvard University and the University of Pennsylvania. At baseline in 1962 or 1966, men (mean age, 45.9 years) reported their weight, height, and other risk factors. They also had had their weight and height measured at university entry (mean age, 18.5 years). Participants were followed from baseline to 1998 for type 2 diabetes.
RESULTS: During follow-up, 1223 men developed type 2 diabetes. Weight gain significantly increased the risk of this disease. The multivariate relative risks associated with BMI change from university entry to baseline of <-0.5, +/-0.5, >0.5 to 1.0, >1.0 to 1.5, >1.5 to 2.0, >2.0 to 3.0, and >3.0 kg/m(2) per decade were 0.88, 1.00 (referent), 1.29, 2.09, 2.69, 4.67, and 7.02, respectively (p for trend < 0.0001). Even among men with a low initial BMI < 21 kg/m(2), weight gain significantly increased risk; the corresponding relative risks were (no cases), 1.00 (referent), 1.00, 1.93, 2.47, 4.82, and 7.68, respectively (p for trend < 0.0001). DISCUSSION: A low initial BMI does not ameliorate the increase in risk of type 2 diabetes with weight gain. Avoidance of weight gain, even among lean individuals, is important to reduce the risk of this disease.

Entities:  

Mesh:

Year:  2005        PMID: 15919849     DOI: 10.1038/oby.2005.109

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  35 in total

1.  Peroxisome proliferator-activated receptor delta (PPARD) genetic variation and type 2 diabetes in middle-aged Chinese women.

Authors:  Raquel Villegas; Scott Williams; Yutang Gao; Qiuyin Cai; Honglan Li; Tom Elasy; Hui Cai; Todd Edwards; Yong-Bing Xiang; Wei Zheng; Jirong Long; Xiao Ou Shu
Journal:  Ann Hum Genet       Date:  2011-09       Impact factor: 1.670

2.  Increased plasma magnesium concentrations 3 years after biliopancreatic diversion with duodenal switch.

Authors:  Jakob Hedberg; Arvo Haenni
Journal:  Obes Surg       Date:  2012-11       Impact factor: 4.129

3.  Short-term weight change and fluctuation as risk factors for type 2 diabetes in Finnish male smokers.

Authors:  Merja Kataja-Tuomola; Jari Sundell; Satu Männistö; Mikko J Virtanen; Jukka Kontto; Demetrius Albanes; Jarmo Virtamo
Journal:  Eur J Epidemiol       Date:  2010-03-30       Impact factor: 8.082

4.  High body mass index is an important risk factor for the development of type 2 diabetes.

Authors:  Hironobu Sanada; Hirohide Yokokawa; Minoru Yoneda; Junichi Yatabe; Midori Sasaki Yatabe; Scott M Williams; Robin A Felder; Pedro A Jose
Journal:  Intern Med       Date:  2012-07-15       Impact factor: 1.271

5.  Wireless pH-metry at the gastrojejunostomy after Roux-en-Y gastric bypass: a novel use of the BRAVO™ system.

Authors:  Jakob Hedberg; Hans Hedenström; Magnus Sundbom
Journal:  Surg Endosc       Date:  2011-02-07       Impact factor: 4.584

6.  The FTO obesity gene. Genotyping and gene expression analysis in morbidly obese patients.

Authors:  Carina Zabena; José L González-Sánchez; María T Martínez-Larrad; Antonio Torres-García; Jesús Alvarez-Fernández-Represa; Arturo Corbatón-Anchuelo; Milagros Pérez-Barba; Manuel Serrano-Ríos
Journal:  Obes Surg       Date:  2008-10-15       Impact factor: 4.129

Review 7.  Modeling obesity histories in cohort analyses of health and mortality.

Authors:  Samuel H Preston; Neil K Mehta; Andrew Stokes
Journal:  Epidemiology       Date:  2013-01       Impact factor: 4.822

8.  Adult weight gain and diabetes among African American and white adults in southeastern US communities.

Authors:  Sarah S Cohen; Lisa B Signorello; William J Blot
Journal:  Prev Med       Date:  2009-10-27       Impact factor: 4.018

9.  Changes in body weight predict CKD in healthy men.

Authors:  Seungho Ryu; Yoosoo Chang; Hee-Yeon Woo; Soo-Geun Kim; Dong-Il Kim; Won Sool Kim; Byung-Seong Suh; Nam-Kyong Choi; Jong-Tae Lee
Journal:  J Am Soc Nephrol       Date:  2008-05-21       Impact factor: 10.121

Review 10.  Adiposopathy is a more rational treatment target for metabolic disease than obesity alone.

Authors:  Harold Bays; Carlos A Dujovne
Journal:  Curr Atheroscler Rep       Date:  2006-03       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.